Clinical Study

TET2 Mutations in Ph-Negative Myeloproliferative Neoplasms: Identification of Three Novel Mutations and Relationship with Clinical and Laboratory Findings

Table 2

TET2 mutations in MPN patients.

ā€‰Sequence locationEffectcDNAPatient ID (diagnosis)

p.P177fsExon 3Frameshiftc.530delCP39 (MPN-U)
p.P411delExon 3Deletionc.1232_1234delCCTP98 (TE)
p.C1298delExon 7Deletionc.3890_3892delGATP42 (MPN-U)
p.Q652fs*Exon 3Frameshiftc.1954delCP65 (MPN-U)
p.R1572W*Exon 11Missensec.4714C>TP23 (PV)
p.V1718L*Exon 11Missensec.5152G>TP21, P25 (TE, PV)

ā€‰*Novel mutations.